NOVEMBER/DECEMBER 2000

Vol 7, No 6 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• be aware of changes in immune reactions with aging,
• recognize changes in hematopoietic reserve,
• prescribe appropriate treatment for brain tumors in the elderly,
• consider neoadjuvant hormone therapy for elderly breast cancer patients, and
• be familiar with nutrition and the surgical oncology patient.

This program was planned in accordance with ACCME Essentials.

Release Date: November 1, 2000
Expiration Date: November 1, 2001

1. The 5-year survival rate for patients with glioblastoma multiforme is approximately 20% in those under 35 years of age. What is the rate for those older than age 55?

a. 40%
b. 20%
c. 10%
d. 1%

2. Generally, the production of hemopoietic cytokines with increasing age is probably:

a. unchanged
b. increased
c. reduced
d. unknown

3. Proposed NCCN guidelines to ameliorate the risk of myelosuppression from cytotoxic chemotherapy using a program similar to CHOP in older persons with cancer suggest the use of:

a. G-CSF or GM-CSF over age 70
b. G-CSF or GM-CSF over age 65
c. G-CSF or GM-CSF over age 80
d. cytokines only if prior sepsis